214 related articles for article (PubMed ID: 26592666)
21. Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling.
Hsieh TJ; Chen R; Zhang SL; Liu F; Brezniceanu ML; Whiteside CI; Fantus IG; Ingelfinger JR; Hamet P; Chan JS
Kidney Int; 2006 Mar; 69(6):1005-15. PubMed ID: 16528250
[TBL] [Abstract][Full Text] [Related]
22. Histone lysine methylation in diabetic nephropathy.
Sun GD; Cui WP; Guo QY; Miao LN
J Diabetes Res; 2014; 2014():654148. PubMed ID: 25215303
[TBL] [Abstract][Full Text] [Related]
23. The role of osteopontin in the development of albuminuria.
Lorenzen J; Shah R; Biser A; Staicu SA; Niranjan T; Garcia AM; Gruenwald A; Thomas DB; Shatat IF; Supe K; Woroniecki RP; Susztak K
J Am Soc Nephrol; 2008 May; 19(5):884-90. PubMed ID: 18443355
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptor.
Gilbert RE; Huang Q; Thai K; Advani SL; Lee K; Yuen DA; Connelly KA; Advani A
Kidney Int; 2011 Jun; 79(12):1312-21. PubMed ID: 21389970
[TBL] [Abstract][Full Text] [Related]
25. Targeting epigenetic regulators for treating diabetic nephropathy.
Kushwaha K; Garg SS; Gupta J
Biochimie; 2022 Nov; 202():146-158. PubMed ID: 35985560
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic modifications in the pathogenesis of diabetic nephropathy.
Reddy MA; Tak Park J; Natarajan R
Semin Nephrol; 2013 Jul; 33(4):341-53. PubMed ID: 24011576
[TBL] [Abstract][Full Text] [Related]
27. Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1.
Metge BJ; Liu S; Riker AI; Fodstad O; Samant RS; Shevde LA
Oncology; 2010; 78(1):75-86. PubMed ID: 20215788
[TBL] [Abstract][Full Text] [Related]
28. Identification of promoter regions involved in cell- and developmental stage-specific osteopontin expression in bone, kidney, placenta, and mammary gland: an analysis of transgenic mice.
Higashibata Y; Sakuma T; Kawahata H; Fujihara S; Moriyama K; Okada A; Yasui T; Kohri K; Kitamura Y; Nomura S
J Bone Miner Res; 2004 Jan; 19(1):78-88. PubMed ID: 14753740
[TBL] [Abstract][Full Text] [Related]
29. Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis.
Sun J; Wang Y; Cui W; Lou Y; Sun G; Zhang D; Miao L
J Diabetes Res; 2017; 2017():7242384. PubMed ID: 28695133
[TBL] [Abstract][Full Text] [Related]
30. Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs.
Sankrityayan H; Kulkarni YA; Gaikwad AB
Pharmacol Res; 2019 Mar; 141():574-585. PubMed ID: 30695734
[TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
32. Glucose-independent persistence of PAI-1 gene expression and H3K4 tri-methylation in type 1 diabetic mouse endothelium: implication in metabolic memory.
Takizawa F; Mizutani S; Ogawa Y; Sawada N
Biochem Biophys Res Commun; 2013 Mar; 433(1):66-72. PubMed ID: 23454124
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.
Godino A; Jayanthi S; Cadet JL
Epigenetics; 2015; 10(7):574-80. PubMed ID: 26023847
[TBL] [Abstract][Full Text] [Related]
34. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
35. Histone Modifications in Major Depressive Disorder and Related Rodent Models.
Deussing JM; Jakovcevski M
Adv Exp Med Biol; 2017; 978():169-183. PubMed ID: 28523546
[TBL] [Abstract][Full Text] [Related]
36. Analysis of HDAC1-mediated regulation of Runx2-induced osteopontin gene expression in C3h10t1/2 cells.
Zhang Z; Deepak V; Meng L; Wang L; Li Y; Jiang Q; Zeng X; Liu W
Biotechnol Lett; 2012 Feb; 34(2):197-203. PubMed ID: 21972143
[TBL] [Abstract][Full Text] [Related]
37. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic and genetic analysis of p16 in dermal fibroblasts from type 1 diabetic patients with nephropathy.
Zeng L; Kanwar YS; Amro N; Phillips C; Molitch M; Batlle D; Danesh FR
Kidney Int; 2003 Jun; 63(6):2094-102. PubMed ID: 12753296
[TBL] [Abstract][Full Text] [Related]
39. Drug Addiction and Histone Code Alterations.
Kim HD; Call T; Magazu S; Ferguson D
Adv Exp Med Biol; 2017; 978():127-143. PubMed ID: 28523544
[TBL] [Abstract][Full Text] [Related]
40. Diabetes mellitus increases endothelin-1 gene transcription in rat kidney.
Hargrove GM; Dufresne J; Whiteside C; Muruve DA; Wong NC
Kidney Int; 2000 Oct; 58(4):1534-45. PubMed ID: 11012888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
